Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. A. Martínez-García, F. Capote, F. Campos-Rodriguez, P. Lloberes, M. J. Diaz de Atauri, M. Somoza, F. Masa, M. Gonzalez, L. Sacristan, F. Barbé, J. Duran-Cantolla, J. M. Montserrat, On Behalf of Spanish Sleep Network (Valencia, Seville, Barcelona, Madrid, Terrassa, Cáceres, Santander, Alicante, Lleida, Vitoria, Spain). LATE-BREAKING ABSTRACT: Effect of CPAP treatment on blood pressure levels in resistant hypertension. A multicenter randomized study from the Spanish sleep network (NCT00616265). Eur Respir J 2012; 40: Suppl. 56, 3864

Member's Comments

No comment yet.

Related content which might interest you: Effect of continuous positive airway pressure (CPAP) on resistant hypertension. A randomised, controlled study Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Effect of the continuous positive airway pressure in apneic patients with resistant hypertension: results from the randomized controlled RHOOSAS study Source: International Congress 2017 – CPAP therapy Year: 2017 LATE-BREAKING ABSTRACT: COPD-associated severe pulmonary hypertension (COPDPH): results of a 16-weeks prospective multicenter, double-blind, placebo-controlled randomized clinical trial (RCT) [SPHERIC-1 (http://clinicaltrials.gov/ct2/show/NCT01441934)] investigating the effect of sildenafil citrate (Sld) on pulmonary vascular resistance (PVR) and PaO2. Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019 Prospective cohort study of patients complaining of high pressure with CPAP/APAP (PAP) who switch to bi-level PAP (VAuto) as second-line therapy: POP-IN study Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Impact of a short rehabilitation program on fat visceral and blood pressure on patients with obstructive sleep apnea syndrome (OSAS). A randomized controlled study Source: Annual Congress 2007 - Pulmonary rehabilitation beyond training Year: 2007 PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH) Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 The effect of early use of continuous positive airway pressure (CPAP) therapy to treat acute atelectasis after cardiac surgery: Randomized study Source: Annual Congress 2011 - Sleep and weight: heavy under pressure Year: 2011 LATE-BREAKING ABSTRACT: Treating the most diseased segments in patients with severe emphysema: 6 month results from the STEP-UP randomized controlled trial (RCT) Source: International Congress 2015 – Advances in therapeutic bronchoscopy Year: 2015 Fixed pressure (FP) versus auto-adjusting continuous positive airway pressure (autoCPAP): Comparison of efficacy in reducing blood pressure, a randomized controlled trial Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013 Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019 Year: 2020 Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study Source: Eur Respir J 2001; 18: 630-634 Year: 2001 The Pickwick randomized clinical trial: long-term positive airway pressure therapy in obesity hypoventilation syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Effect of 3-month CPAP treatment on blood pressure and serum aldosterone concentration in patients with resistant hypertension Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013 Late Breaking Abstract - FACE: Cluster phenotyping predicting outcomes in a prospective multicenter cohort study of chronic heart failure (CHF) patients with central sleep disorder breathing (SDB) indicated for adaptive servo ventilation (ASV). Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019 CPAP impact on memory processes in OSA patients, a randomized sham controlled trial Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016 Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Mandibular advancement device versus continuous positive airway pressure for treatment of obstruvtive sleep apnea syndrome: a randomized crossover trial Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial Source: Eur Respir J, 52 (4) 1801177; 10.1183/13993003.01177-2018 Year: 2018